Zobrazeno 1 - 10
of 27
pro vyhledávání: '"George A. Margaritopoulos"'
Autor:
Christoph Lederer, Monika Storman, Adam Domonkos Tarnoki, David Laszlo Tarnoki, George A. Margaritopoulos, Helmut Prosch
Publikováno v:
Breathe, Vol 20, Iss 1 (2024)
High-resolution computed tomography (HRCT) plays a pivotal role in the diagnosis and management of interstitial lung diseases (ILDs), particularly given the approval of antifibrotic agents for conditions like idiopathic pulmonary fibrosis and progres
Externí odkaz:
https://doaj.org/article/30c96bc1f2ac4e08ba8115beeed669f7
Autor:
George A. Margaritopoulos, Athanasia Proklou, Athina Trachalaki, Diana Badenes Bonet, Maria Kokosi, Vasilis Kouranos, Felix Chua, Peter George, Elisabetta A. Renzoni, Anand Devaraj, Sujal Desai, Andrew G. Nicholson, Katerina M. Antoniou, Athol U. Wells
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Background Overnight desaturation predicts poor prognosis across interstitial lung diseases (ILDs). The aim of the present study was to investigate whether nocturnal desaturation is associated with pulmonary vasculopathy and mortality. Methods A retr
Externí odkaz:
https://doaj.org/article/ad03645cfd8c41819e98ef95d845120f
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory disorders. The development of connective tissue disease-associated interstitial lung disease (CTD-ILD) is a key complication associated with significant morbidity and
Externí odkaz:
https://doaj.org/article/bb112d83ca8148c4ba79970fc9219462
Autor:
Antoniya Kamenova, Tara Sathyamoorthy, Gillian Bain, Patrizia Viola, George A. Margaritopoulos
Publikováno v:
Breathe, Vol 18, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/fbbef543cf8240a4870b39fb3819582f
Autor:
Eliza Tsitoura, Athina Trachalaki, Eirini Vasarmidi, Semeli Mastrodemou, George A. Margaritopoulos, Maria Kokosi, Dionysios Fanidis, Apostolos Galaris, Vassilis Aidinis, Elizabeth Renzoni, Nikos Tzanakis, Athol U. Wells, Katerina M. Antoniou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF) and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of progression despite management. This group of patients has been colle
Externí odkaz:
https://doaj.org/article/db8b3a2a2f2d4bf09d7b6d455f17bed9
Autor:
George A. Margaritopoulos, Athina Trachalaki, Athol U. Wells, Eirini Vasarmidi, Eleni Bibaki, George Papastratigakis, Stathis Detorakis, Nikos Tzanakis, Katerina M. Antoniou
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Pirfenidone is an antifibrotic compound approved for the treatment of idiopathic pulmonary fibrosis (IPF). We present our real-world experience in terms of Pirfenidone’s effect on mortality and adverse events profile outside the
Externí odkaz:
https://doaj.org/article/c64c732659604ca0be6458d87bcda818
Autor:
George A. Margaritopoulos, Eirini Vasarmidi, Joseph Jacob, Athol U. Wells, Katerina M. Antoniou
Publikováno v:
European Respiratory Review, Vol 24, Iss 137, Pp 428-435 (2015)
For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases. In the recent years, attention has also focused on the role of
Externí odkaz:
https://doaj.org/article/a7e0734d984b4b8c967221a6284eae96
Autor:
Athanasia Proklou, Maria Bolaki, Evangelia E. Vassalou, Eleni Bibaki, Eirini Vasarmidi, George A. Margaritopoulos, Apostolos H. Karantanas, Nikolaos Tzanakis, Katerina M. Antoniou
Publikováno v:
Breathe, Vol 14, Iss 2, Pp e59-e67 (2018)
Externí odkaz:
https://doaj.org/article/84df45a25e9d4a4cb77edb57133b1d87
Publikováno v:
European Respiratory Review, Vol 27, Iss 148 (2018)
Interstitial lung diseases in general, and idiopathic pulmonary fibrosis in particular, are complex disorders with multiple pathogenetic pathways, various disease behaviour profiles and different responses to treatment, all facets that make personali
Externí odkaz:
https://doaj.org/article/1890787128224914942012ed8e880e4b
Autor:
Sophia Schiza, Charalampos Mermigkis, George A. Margaritopoulos, Zoi Daniil, Sergio Harari, Venerino Poletti, Elizabetta A. Renzoni, Olga Torre, Dina Visca, Isolde Bouloukaki, George Sourvinos, Katerina M. Antoniou
Publikováno v:
European Respiratory Review, Vol 24, Iss 136, Pp 327-339 (2015)
The prevalence of obstructive sleep apnoea (OSA) is continuously increasing in patients with idiopathic pulmonary fibrosis (IPF) and, for the first time, the recent IPF guidelines recognise OSA as an important associated comorbidity that can affect p
Externí odkaz:
https://doaj.org/article/a2ec3406417f49c3b5e4a326f98b694a